rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2009-5-1
|
pubmed:abstractText |
The safety and tolerability profiles of antidepressants can often influence the treatment choices of clinicians treating major depressive disorder. The purpose of this investigation was to characterize the safety and tolerability of desvenlafaxine (administered as desvenlafaxine succinate) in treating depression.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1092-8529
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
183-95
|
pubmed:meshHeading |
pubmed-meshheading:19407730-Adolescent,
pubmed-meshheading:19407730-Adult,
pubmed-meshheading:19407730-Aged,
pubmed-meshheading:19407730-Antidepressive Agents, Second-Generation,
pubmed-meshheading:19407730-Cyclohexanols,
pubmed-meshheading:19407730-Depressive Disorder, Major,
pubmed-meshheading:19407730-Dose-Response Relationship, Drug,
pubmed-meshheading:19407730-Double-Blind Method,
pubmed-meshheading:19407730-Electrocardiography,
pubmed-meshheading:19407730-Female,
pubmed-meshheading:19407730-Humans,
pubmed-meshheading:19407730-Liver Function Tests,
pubmed-meshheading:19407730-Male,
pubmed-meshheading:19407730-Middle Aged,
pubmed-meshheading:19407730-Suicide,
pubmed-meshheading:19407730-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.
|
pubmed:affiliation |
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA. ahc8v@virginia.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|